3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow Mibefradil: new trials by email Literature Review of Mibefradil trials Research Report on Mibefradil
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TAU-2014-1: Mibefradil and Hypofractionated Re-Irradiation Therapy in Recurrent GBM Mibefradil with Radiation - Glioblastoma Multiforme (GBM) | Phase 1 | Completed | Cavion, Inc. | 18 | 2014-08-01 | 2019-07-24 |
| Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma temozolomide, 3'-deoxy-3'-[18F]fluorothymidine, pharmacological study - Brain and Central Nervous System Tumors | Phase 1 | Completed | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 28 | 2012-05-31 | 2019-05-22 |
| Safety Study of Mibefradil When Given Four Times a Day in Healthy Volunteers mibefradil, Placebo - Healthy | Phase 1 | Completed | Cavion, Inc. | 30 | 2012-02-01 | 2019-04-08 |
Glioblastoma (2) · Astrocytoma (1) · Brain Neoplasms (1) · Central Nervous System Neoplasms (1) · Ependymoma (1) · Glioma (1) · Oligodendroglioma (1)
Cavion, Inc. (2) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)
United States (3)
Matthias Holdhoff, MD (1) · Ranjit S Bindra, MD PhD (1) · Scott Rasmussen, MD (1)